Human Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Cerebellar Ataxia: A Case Report

To date, there is no curable treatment option for non-hereditary degenerative cerebellar ataxia. Here we report the case of a patient with sporadic adult-onset ataxia (SAOA) who underwent allogeneic bone marrow-derived mesenchymal stem cell (MSC) therapy via the intrathecal route. A 60-year-old male...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Pan-Woo, Park, Sangmin, Kang, Kyunghun, Lim, Yong-Hyun, Kim, Sang Ryong, Suk, Kyoungho, Kim, Kyung Suk, Lee, Ho-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067136/
https://www.ncbi.nlm.nih.gov/pubmed/33915966
http://dx.doi.org/10.3390/medicina57040334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067136/
https://www.ncbi.nlm.nih.gov/pubmed/33915966
http://dx.doi.org/10.3390/medicina57040334

Ejemplares similares